Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT

Clinical trial NCT01822093 · COMPLETED

Trial details

NCT number: NCT01822093
Sponsor: Cell Medica Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ADV Infection Post Allo-HSCT

Start date: 2012-12-01
Primary completion: 2016-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.